FDA Inspection 871578 — Sever Pharma Solutions

Sever Pharma Solutions — FEI 3004620701

The FDA completed an inspection of Sever Pharma Solutions on March 27, 2014 in Malmo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 27, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Malmo (Sweden)

Citations

IDCFRDescription
139521 CFR 211.103Actual vs. theoretical yields not determined